Biotech & Medtech
Biotech & Medtech news — Thursday 08 October 2026
36 stories from 4 sources, every one in English. Each links to its publisher.
-
Trump administration investigates 9 universities for alleged visa fraud
STAT News
This story has been updated. The Trump administration announced Thursday that it is investigating nine universities for alleged fraud related to visas commonly used by postdoctoral researchers, a core part of the nation’s biomedical…
-
Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases
MedCity News
Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the basis of partnerships with big pharma and lead to the…
-
STAT+: House Democrat seeks to scrap No Surprises Act’s costly arbitration process
STAT News
A new proposal in Congress to scrap a surprise billing ban’s controversial arbitration system will need to to survive an onslaught of attacks from provider groups, for whom arbitration has been a gold mine. After Rep. Frank Pallone…
-
HHS launches new plan to strengthen vaccine injury research, reporting
BioPharma Dive
Spearheaded by vaccine skeptic Robert F. Kennedy Jr., the initiative will involve a new NIH clinic, an updated monitoring system and reimbursements for doctors who report suspected side effects.
-
Vitalize Secures $31M To Help Hospitals Manage Labor, Capacity
MedCity News
The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital and MemorialCare Innovation Fund. The post Vitalize Secures $31M To Help Hospitals Manage…
-
NIH funding uncertainty thwarts U.S. researchers
STAT News
How has the National Institutes of Health been spending its budget? Why are biotech investors feeling gloomy? And what is the most quintessential Boston movie? We discuss all that and more on this week’s episode of “The Readout LOUD,”…
-
Viatris boosts pain drug portfolio with $1.7B buyout of Pacira
BioPharma Dive
The deal hands Viatris two non-opioid pain treatments that booked nearly $700 million in 2025 but could soon lose patent protection. Viatris vowed to use its “intellectual property expertise” to sustain sales.
-
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
STAT News
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! I had…
-
Argenx falls as Sjögren’s setback offsets celiac drug progress
BioPharma Dive
A monitoring board’s recommendation to stop the study for futility took Wall Street by surprise, removing one more ‘blockbuster expansion opportunity’ for Vyvgart.
-
STAT+: The fresh faces that may shake up key Senate committees ahead of midterms
STAT News
STAT has announced its tenth class of Wunderkinds . It’s an impressive group of researchers and clinicians who are making an impact in science and medicine early in their careers. Send news tips and go-getters to…
-
In the hunt for reverse merger targets, Caribou could be prized game
BioPharma Dive
The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.
-
STAT+: Roche goes beyond licensing in deal with Chinese biotech
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Let’s get straight to the news. The need-to-know this morning Bristol Myers Squibb said Zenbexus…
-
FDA says its safety review of abortion pill will continue into next year
STAT News
WASHINGTON — The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug’s use…
-
STAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease
STAT News
Argenx said Thursday that its blockbuster drug Vyvgart didn’t outperform placebo in a Phase 3 trial of patients with Sjögren’s disease, a chronic autoimmune disorder. It’s an unusual setback for Argenx, which has racked up a series of wins…
-
AI Can Flag Cognitive Decline Earlier — Health Systems Still Own What Happens Next
MedCity News
Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record. Health systems need to decide, in advance, how a risk signal becomes a clinically accountable pathway. The post…
-
STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more
STAT News
Top of the morning to you, and a fine one it is. Clear blue skies are hovering over the Pharmalot campus, where a cool breeze is wafting by and the official mascots are bounding about the grounds in search of critters. As for us, we are…
-
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
STAT News
Roche is digging deeper into the biotech industry in China, striking a new partnership with a drug startup there. But rather than licensing the startup’s clinical-stage medicines, Roche is enlisting it to discover new ones, signaling a…
-
The Nobel boys club (again)
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . If you’re into online gambling, I think it’s worth mentioning that STAT predicted optogenetics’ success and a potential…
-
STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
STAT News
“Don’t wait. Choose to be informed.” That’s the call to action that patients will find on the site for digital health company Everlywell, which has offered at-home lab tests directly to consumers for a decade. But last week, it wasn’t…
-
Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality
STAT News
Of all the factors that can increase a person’s risk of breast cancer, age is among the most significant. Almost half of people diagnosed with breast cancer are at least 65 , and about 20% are 75 or older. Despite these rates, older women…
-
Opinion: England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.?
STAT News
In September, “Baywatch” star Pamela Anderson opened up about her hepatitis C diagnosis in the 1990s. “It was a death sentence,” she said while accepting the Award of Courage from amfAR, an organization supporting HIV/AIDS research and…
-
STAT+: Biotech companies are struggling to navigate Trump’s new tariffs
STAT News
WASHINGTON — A broad tariff on imported pharmaceuticals took effect at the end of September, and some biopharma companies and the industry group that represents them say many are being left in the dark on how to get exemptions. The Trump…
-
STAT+: Dozens of Democrats vie for slots on key House health committees
STAT News
WASHINGTON — Two powerful House committees with jurisdiction over health care policies are expected to get several fresh faces after the midterms. The combined impact of a potential wave election and multiple departing lawmakers could open…
-
Opinion: How CMS plans to fix a major flaw in the 340B drug discount program
STAT News
Some Medicare patients owe more in coinsurance than the hospital paid for their drug. That arithmetic sounds impossible. It is a consequence of the 340B drug discount program and Medicare’s payment formula. Now the Department of Health and…
-
A mother-daughter quest to find fellow members of an ultra-rare genetic community
STAT News
Reporting for this story was supported by the Pulitzer Center. “Don’t Google,” the pediatric geneticist warned us on a sunny October afternoon in 2020. Read the rest… © Camille MacMillin/STAT
-
The Modular CMA-ES: A Framework for Modern Evolution Strategies
arXiv cs.NE (Neural／Bio)
arXiv:2610.09699v1 Announce Type: new Abstract: Since their introduction, modern evolution strategies, such as the Covariance Matrix Adaptation Evolution Strategy (CMA-ES), have become established as powerful methods for continuous…
-
Evolutionary Architecture Search for Chlorophyll-$a$ Prediction in Lakes using Sentinel-2
arXiv cs.NE (Neural／Bio)
arXiv:2610.10496v1 Announce Type: new Abstract: Small tabular datasets with expert-designed spectral features are the norm in operational Earth observation, and the networks applied to them are typically hand-designed. We revisit one such…
-
HCPN-GCN: Scaling Hierarchical Prototype Networks with Cone Geometry for Continual Graph Learning
arXiv cs.NE (Neural／Bio)
arXiv:2610.08823v1 Announce Type: cross Abstract: Continual Graph Learning (CGL) aims to incrementally learn from graph-structured data while preserving knowledge acquired from previous tasks. A major challenge in this setting is…
-
Synthetic Benchmarks Overstate Forward-Forward Scaling: Real-Data Limits of Layer-Local Training
arXiv cs.NE (Neural／Bio)
arXiv:2606.06539v2 Announce Type: replace-cross Abstract: Forward-Forward (FF) learning [Hinton, 2022] replaces backpropagation with strictly layer-local goodness updates. Recent FF-CNN work has narrowed the gap to BP on 32x32 benchmarks…
-
Operator Calculus for Population-Based Optimization: Modular Convergence and Finite-Population Guarantees
arXiv cs.NE (Neural／Bio)
arXiv:2606.14289v3 Announce Type: replace-cross Abstract: Population-based optimizers combine update rules such as mutation, selection, and recombination. When one rule changes, it is often unclear which convergence guarantees survive or…
-
A Connectome Test of the Fly Hashing Algorithm
arXiv cs.NE (Neural／Bio)
arXiv:2610.09114v1 Announce Type: new Abstract: Dasgupta, Stevens and Navlakha (2017) showed that the Drosophila olfactory circuit, modelled as a random sparse projection followed by winner-take-all, is a locality-sensitive hash that beats…
-
Relocating Nonlinearity: How a Downstream Learner Reshapes What Genetic Programming Must Evolve
arXiv cs.NE (Neural／Bio)
arXiv:2610.09347v1 Announce Type: new Abstract: Genetic programming was conceived as a way of evolving solutions: the program is the answer, and fitness is the error of its own output. A substantial line of work instead makes the program…
-
Evaluating the Transfer of Co-Evolved Communication from 2D to 3D Simulation
arXiv cs.NE (Neural／Bio)
arXiv:2610.09280v1 Announce Type: cross Abstract: This work examines the transfer of a co-evolved communication mechanism between two robotic agents from a discrete two-dimensional (2D) simulator to a three-dimensional simulator with real…
-
Evolve on the Host, Predict on the Edge: Deploying Online Neuroevolutionary Architecture Search for Cross-sectional Stock Return Prediction
arXiv cs.NE (Neural／Bio)
arXiv:2610.10038v1 Announce Type: cross Abstract: Accurate forecasting models are usually large, expensive to update online, and fixed in architecture once trained. We apply ONE-NAS, an online neuroevolutionary architecture search that…
-
Learning in the Recurrent State: Gradient Descent with Linear Recurrent Networks
arXiv cs.NE (Neural／Bio)
arXiv:2410.11687v4 Announce Type: replace-cross Abstract: In-context learning lets a sequence model adapt to a new task from examples in its input. A prominent line of work shows how self-attention can be constructed to implement gradient…
-
Circuit realization and hardware linearization of monotone operator equilibrium networks
arXiv cs.NE (Neural／Bio)
arXiv:2509.13793v3 Announce Type: replace-cross Abstract: It is shown that the port behavior of a resistor-diode network corresponds to the solution of a ReLU monotone operator equilibrium network (a neural network in the limit of infinite…